Global Ultrasonic Nebulizer Market Estimated to Witness High Growth Owing To Increasing Prevalence of Respiratory Diseases
Ultrasonic nebulizers are medical devices that deliver medication to the lungs through nebulization. They work by using high frequency ultrasound waves to vibrate a mesh or plate inside the device that breaks various liquid and suspensions into a fine mist to be inhaled. Ultrasonic nebulizers are easy to use, portable, and provide a more consistent and precise drug delivery for treating conditions like asthma and COPD compared to jet nebulizers.
The global ultrasonic nebulizer market was
valued at US$ 218.3 million in 2023 and is expected to exhibit a CAGR of 5.9%
over the forecast period 2023 to 2030, as highlighted in a new report published
by CoherentMI.
Market Dynamics:
The increasing prevalence of respiratory diseases like asthma and COPD has been
a major driver for the growth of the global ultrasonic nebulizer market.
Chronic respiratory diseases are among the most common non-communicable
diseases globally. According to recent estimates by the World Health Organization
(WHO), around 235 million people suffer from asthma, while over 3.2 million die
from COPD each year worldwide. The widespread adoption of ultrasonic nebulizers
for administering bronchodilators and other respiratory drugs for treating such
diseases has propelled market growth over the years. Additionally, ultrasonic
nebulizers are portable, easy-to-use, and provide a more consistent drug
delivery compared to jet nebulizers. This has resulted in their greater
preference over jet nebulizers, further stimulating market expansion.
Global Ultrasonic Nebulizer Market
Segmentation
By Product Type
Large-volume ultrasonic nebulizers
Small-volume ultrasonic nebulizers
By Application
COPD
Cystic Fibrosis
Asthma
Others
By End User
Hospitals and Clinics
Emergency Centers
Home Healthcare
Others
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
SWOT Analysis
Strength: Ultra sonic nebulizers do
not require assembly or disassembly of parts. They have a compact size and are
easy to use. Their output is very consistent without any wastage which makes
them highly efficient.
Weakness: Ultra sonic nebulizers
have a higher initial cost compared to mesh nebulizers. They tend to deliver
large particle sizes which are not ideal for all conditions. Battery life is
shorter than compressor nebulizers.
Opportunity: Growing prevalence of
respiratory diseases worldwide is fueling the demand for effective nebulization
devices. Ultra sonic nebulizers offer benefits over other types which can help
increase their market share over time. Untapped markets in developing regions
provide scope for expansion.
Threats: Availability of cheaper
alternatives like mesh nebulizers poses pricing pressure. Strict regulations
pertaining to sound levels can impact product approvals. Dependency on key
components imported from other countries increases risks associated with supply
chain disruptions.
Key Takeaways
The Global
Ultrasonic Nebulizer Market Size is expected to witness high growth
over the forecast period of 2023 to 2030. Growing respiratory disease burden
globally and aging population are major demand drivers in this market. The
market size is projected to reach US$ 218.3 million by 2023 registering a CAGR
of 5.9% during the forecast period.
Regional Analysis: North America
currently dominates the ultrasonic nebulizer market owing to high healthcare
expenditure and rapid adoption of new medical technologies in the region. Asia
Pacific is expected to be the fastest growing market led by countries like
China and India due to large population base and increasing healthcare
awareness. Prevalence of respiratory disorders is also rising rapidly Asia
Pacific creating high growth opportunities.
Key Players: Key players operating
in the ultrasonic nebulizer market are Philips
Healthcare, Omron, PARI Medical, BD, Agilent Technologies, Airssential, Allied
Healthcare Products, Briggs Healthcare, CareFusion, GF Health Products, Medline
Industries, Medquip, DeVilbiss Healthcare, Medisana, Precision Medical,
Rossmax, Salvatore Robuschi, Shenzhen Shenkang, VENTA-tec, and WalkMed.
These companies are focused on new product launches and expanding regional
presence to strengthen their market position and cater to the growing demand.
Reasons to Purchase Global Ultrasonic
Nebulizer Market Report:
1. Enhance the decision-making
process by understanding the strategies that underpin commercial interest with
respect to products, segmentation, and industry verticals.
2. Develop/modify business expansion
plans by using substantial growth offerings in developed and emerging markets.
3. Save and reduce time carrying out
entry-level research by identifying the growth, size, leading players, and
segments in the Global Ultrasonic Nebulizer Market.
FAQ’s
Q.1 What will the market development pace of the Global
Ultrasonic Nebulizer Market?
Q.2 What are the sales, revenue, and price analysis of the
top players of the Global Ultrasonic Nebulizer Market?
Explorer more information on this topic, Please visit @
https://www.pressreleasebulletin.com/global-ultrasonic-nebulizer-market-demand-and-forecast-analysis/
Comments
Post a Comment